Literature DB >> 17724366

Admissions to a medical intensive care unit related to adverse drug reactions.

Anastasia Rivkin1.   

Abstract

PURPOSE: The frequency, severity, and preventability of adverse drug reactions (ADRs) leading to admission in a medical intensive care unit (MICU) were studied.
METHODS: A prospective consecutive 19-week observational study was conducted between December 2004 and May 2005 in the department of critical care medicine at a tertiary care teaching hospital. Patients admitted to the MICU because of an ADR were followed prospectively until hospital discharge or death. The causality, severity, and preventability of each ADR were determined. Duration of MICU stay and overall duration of hospital stay were also assessed.
RESULTS: A total of 281 patients were admitted to the MICU over the 19-week study period. Of these, 21 (7.5%) admissions were ADR related. Of the 21 ADRs analyzed, 3 (14%) were moderate, 14 (67%) were severe, and 4 (19%) were fatal. A total of 18 ADRs (86%) were deemed preventable. Drug interactions were the cause of 12 ADRs (57%), 100% of which were preventable. Aspirin was the most commonly implicated medication (28.6%). Bleeding was the most common ADR admission diagnosis (gastrointestinal bleeding accounted for 33% of all ADRs). ADR-related admissions resulted in an additional 119 total days of MICU stay and an additional 114 days of medical ward stay.
CONCLUSION: The majority of the ADRs for which patients were admitted to an MICU were deemed preventable. Bleeding caused by some combination of nonsteroidal antiinflammatory drugs (NSAIDs), cyclooxygenase-2-selective NSAIDS, aspirin, and clopidogrel was the most common reason for ADR-related MICU admissions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724366     DOI: 10.2146/ajhp060641

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  21 in total

Review 1.  [Clinically relevant pharmacokinetic drug interactions in the intensive care unit: an overview].

Authors:  W Kämmerer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-23       Impact factor: 0.840

2.  Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Authors:  Roberto Leone; Lara Magro; Ugo Moretti; Paola Cutroneo; Martina Moschini; Domenico Motola; Marco Tuccori; Anita Conforti
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

Review 3.  Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.

Authors:  Isabel Spriet; Wouter Meersseman; Jan de Hoon; Sandrina von Winckelmann; Alexander Wilmer; Ludo Willems
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

4.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

5.  [Drug interactions].

Authors:  V Hafner; B Grün; C Markert; D Czock; G Mikus; W E Haefeli
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

Review 6.  Hospitalizations due to preventable adverse reactions-a systematic review.

Authors:  Nidhi S Patel; Tejas K Patel; Parvati B Patel; Viren N Naik; C B Tripathi
Journal:  Eur J Clin Pharmacol       Date:  2016-12-02       Impact factor: 2.953

7.  Characterization of adverse drug reactions causing admission to an intensive care unit.

Authors:  Camilo Rojas-Velandia; Jair Ruiz-Garzón; Juan-Carlos Moscoso-Alcina; Álvaro Vallejos-Narvaéz; Jenny Castro-Canoa; Yuri Bustos-Martínez; Max Flórez-Cutiva; Mabel Contreras-Muñoz; Jully-Carolina Gómez-Gil; Carlos-Alberto Calderón-Ospina
Journal:  Br J Clin Pharmacol       Date:  2017-01-10       Impact factor: 4.335

8.  Drug-related mortality among inpatients: a retrospective observational study.

Authors:  Alfredo José Pardo Cabello; Esperanza Del Pozo Gavilán; Francisco Javier Gómez Jiménez; Carmen Mota Rodríguez; Juan de Dios Luna Del Castillo; Emilio Puche Cañas
Journal:  Eur J Clin Pharmacol       Date:  2016-02-20       Impact factor: 2.953

9.  A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.

Authors:  Pamela L Smithburger; Mitchell S Buckley; Mark A Culver; Sarah Sokol; Ishaq Lat; Steven M Handler; Levent Kirisci; Sandra L Kane-Gill
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

10.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.